Építés alatt – nem éles oldal
Belépés
Fut, nem toborozFázis nélkül

Dietary Management of Gestational Diabetes

A legfontosabb adatok

Ki végzi
Helsinki University Central Hospital
Hol
Finnország1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Fut, nem toboroz
Résztvevők
42 fő vett részt
Kezdés
2018. dec. 3.
Várható befejezés
2027. dec. 30.
A vizsgálat típusa
Beavatkozással járó, 2 csoport
A vizsgált kezelések
  • Carbohydrate restricted diet
  • Plant-protein based diet
A regiszteradat frissítve
2025. szeptember 24.

Ki vehet részt

Nem
Csak nők
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 11 feltétel megnézéseKevesebb

Ki vehet részt

  • Gestational diabetes at enrollment

Ki nem vehet részt

  • Cholesterol medication
  • Drug or alcohol abuse
  • Food allergies or restrictions (other than lactose intolerance)
  • Type 1 or type 2 diabetes
  • Psychiatric illness which affects participation in the study
  • Medication which affects glucose metabolism
  • Gestational weeks exceed 28+6
  • Multiple pregnancy
  • Mother's or father's ethnic background other than Caucasian
  • Factors hampering communication (e.g. lack of Finnish skills)

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

eMOM is a randomized, controlled trial to compare the effects of two different dietary interventions during pregnancy. The comparison is based on tissue glucose content (using continuous glucose monitoring system) in pregnant women and on neonate body composition. The recruited women (n=60) have been diagnosed with gestational diabetes mellitus, and are of Caucasian origin. Of the study diets, one is moderately carbohydrate restricted and the other one is high on plant-based protein with an emphasis on healthy Nordic foods. The study has two two-week study periods that are carried out on approximately gestational weeks 24-28 (period I) and 34-36 (period II). Continuous glucose monitoring and other measurements (accelerometer, 3-day food record, gut microbiota, serum lipids, metabolomics, epigenetics etc.) are done during these study periods. At the beginning of the study, before study period I, the participants are randomized to either one of the intervention diets. The first study period consists of a crossover phase in which the participants receive three days' worth of food according to one of the intervention diets (according to the randomization) after which there is a three-day wash-out period. After the wash-out period, the participants receive three days' worth of food according to the other diet. After the first study period, a nutritionist advises the lastly followed intervention diet to the participant and the diet is followed until delivery. To ensure the diet is followed, the participants gets at least three personal face-to-face counseling sessions, phone calls, mobile reminders, recipes and food items. After delivery, the infant's body composition, epigenetic markers of cord blood and placenta, gut microbiome and urine metabolomics are measured.

A vizsgálat 2 csoportja

  • Carbohydrate restricted dietA vizsgált kezelés

    Dietary intervention: moderately carbohydrate restricted diet. Parallel phase starts after study period I and the diet is followed until labor.

  • Plant-protein based dietA vizsgált kezelés

    Dietary intervention: plant-protein based diet, en emphasis on healthy Nordic foods. Parallel phase starts after study period I and the diet is followed until labor.

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Effects of Guided Dietary Patterns on Metabolic Outcomes in Overweight Pregnant Women With Gestational Diabetes and on Offspring Body Composition
Publikációk
A regiszteradat frissítve
2025. szeptember 24.